Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001094891-25-000002·PAVmed Inc.
Schedule 13G ownership disclosure
PAVMED INC
Common Stock, Par Value $0.001 Per Share · CUSIP: 70387R403
Event date: 2025-02-21
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Tasso Partners, LLC
Shares: 2,574,350.00 · Class: 18.9%
- Dana Carrera
Shares: 2,574,350.00 · Class: 18.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001094891-25-000002
- Form type
- SCHEDULE 13G
- Filer
- PAVmed Inc.
- CIK
- CIK 1624326
- Filed
- Feb 28, 2025
- Reporting period
- Feb 21, 2025
- Description
- Schedule 13G beneficial ownership